Skip to content

Drug interactions

Dasatinib + Lenacapavir

Severity: Moderate

Dasatinib and Lenacapavir: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor and may increase dasatinib exposure, with the effect persisting for months after subcutaneous dosing. This may increase dasatinib toxicity.

What this interaction means in plain words

Dasatinib and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dasatinib belongs to Oncology; Lenacapavir belongs to Anti Virals.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 metabolism of dasatinib by lenacapavir.

What to do

Monitor for dasatinib adverse effects including cytopenias, effusions and QTc, and consider a dasatinib dose reduction.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dasatinib and Lenacapavir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Dasatinib with Lenacapavir?

MediHelp rates the interaction as moderate. Dasatinib and Lenacapavir can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor and may increase dasatinib exposure, with the effect persisting for months after subcutaneous dosing. This may increase dasatinib toxicity.

How serious is the interaction between Dasatinib and Lenacapavir?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for dasatinib adverse effects including cytopenias, effusions and QTc, and consider a dasatinib dose reduction.

What other medicines interact with Dasatinib?

MediHelp also lists interactions of Dasatinib with, for example, Saquinavir, Thioridazine, Adagrasib. The full list is on the Dasatinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in